The LSPedia L5 Country Hub program is dedicated to enhancing the health and well-being of citizens in every country where our technology is deployed by providing a comprehensive track-and-trace solution for pharmaceutical products. Our vision is to achieve complete traceability of medicines from manufacturing, through distribution, to dispensing, ensuring a safe, high-quality distribution chain throughout your country.
Our Country Hub is a robust platform and data repository, delivering real-time transparency, accountability, and verification. Powered by LSPedia's advanced L5 Country Hub technology, it serves as a centralized resource for tracking supply chain events from entry at the ports through the in-country supply chain in accordance with GS1 best practices and guidelines.
With extensive expertise in all areas of the pharmaceutical supply chain, the LSPedia L5 Country Hub team ensures compliance with each country’s serialization and traceability requirements. Our mission is to build a reliable track-and-trace system that safeguards patients, secures the supply chain, and preserves the integrity of medicines in every country where our technology is implemented.
Traceability starts at the point of entry and customs, where comprehensive tracking is initiated to ensure alignment with valid purchase orders placed by verified buyers within the country. These orders must come from authorized trading partners, who have been approved by the relevant regulatory entity, ensuring that only legitimate, quality-assured pharmaceutical products enter the supply chain.
The tracking of medicines at the point of dispensing serves as a crucial verification step to ensure that the pharmaceutical products being provided to patients originate from reputable and authorized sources. This process guarantees that each medicine has been properly authenticated throughout the entire supply chain, from manufacturing through distribution, reinforcing the integrity of the supply chain and ensuring patient safety by preventing the circulation of counterfeit, diverted or substandard products.
Having the ability to monitor medicine quantities and their locations at a national level enables health authorities to swiftly identify potential shortages or regions with heightened demand, as well as the capability to issue and manage recalls. This capability is especially critical during emergencies, allowing for the rapid deployment of resources to areas in need. Additionally, this level of visibility can help detect unusual patterns, such as a sudden increase in the purchasing of addictive drugs, allowing for early intervention and the implementation of necessary safeguards to prevent misuse or abuse.
OneScan suite is the leading DSCSA solution, designed and proven to increase productivity, profitability, and supply chain visibility. LSPedia's seamless, cloud-based compliance solution streamlines the track and trace requirements with little impact on your daily processes.
Contact Us